The Lumosity brain training program improved overall cognitive performance in healthy adults during a 12-week randomized clinical trial, according to findings scheduled for presentation on Wednesday.
The BRIGHT-Mind study enrolled 801 adults aged 25 to 80, with 677 participants completing the primary analysis. Researchers compared those using the Lumosity platform against a control group that engaged with educational videos. Participants in the Lumosity group showed greater improvement on a 12-test cognitive battery, with results indicating a performance gap equivalent to the difference between individuals roughly 6.7 years apart in age.
"People should expect more from brain training than getting better at a game," said Bob Schafer, CEO of Lumos Labs and corresponding author of the study, in a statement provided to News-Medical. "For this reason, we structured BRIGHT-Mind to evaluate Lumosity strictly, utilizing a comparison group that remained mentally active alongside cognitive assessments that were entirely new to the participants."
Beyond standardized testing, the study utilized the Patient Global Impression of Improvement (PGI-I) and the Sheehan Disability Scale (SDS) to measure real-world impact. On the PGI-I, 70% of the Lumosity group reported improvements in concentration, memory and ability to think clearly, compared to 46% of the comparison group.
Participants also reported functional gains on the SDS, which tracks performance in social, work, and home environments. Training sessions for the study lasted 15 to 25 minutes, with 83.6% of the Lumosity cohort completing at least 13 hours of activity over the 12-week period. No adverse events were reported for either the training or the control program.
A subgroup of 220 participants underwent MRI scans to determine if brain training influenced structural markers of aging. In those aged 60 to 80, the Lumosity group showed a more favorable change in brain-predicted age—a difference of approximately 1.5 years compared to the control group.
Researchers said that the Lumosity group exhibited less enlargement of the brain’s ventricles, which typically expand as tissue is lost during the aging process. The study also found better maintenance of cortical thickness in the anterior cingulate cortex, middle temporal gyrus and prefrontal cortex—regions essential for cognitive control and attention.
"It is not uncommon for lifestyle and behavioral modifications to boost cognition without manifesting as visible MRI changes; however, the BRIGHT-Mind trial revealed structural brain variations in older participants within just 12 weeks," said Kelly MacNiven, research scientist and study co-author.
While the study suggests that at-home cognitive training may support brain health, the researchers said that the trial was limited to healthy adults. The findings do not indicate whether similar benefits would occur in individuals with cognitive impairment or neurological conditions.
Further investigation is required to determine the long-term sustainability of these gains after training ceases. "According to BRIGHT-Mind, convenient, home-based cognitive exercises warrant significant consideration as a component of a comprehensive brain health strategy," said Murali Doraiswamy, MBBS, FRCP, Professor in Psychiatry and Neurology at Duke University and a Lumos Labs Scientific Advisor.
The full results of the trial are set for presentation at the 19th Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Boston on November 18, 2026.